Engineering an immune-cell booster for cancer patients

Cancer patients might one day benefit from being administered immune cells from healthy donors. But as things stand, receiving donor cells can cause severe or even fatal immune reactions. A researcher at ETH Zurich has now developed a technology that avoids these.

Leave A Comment

Your email address will not be published. Required fields are marked *